Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease-Reference-Cited by-同舟云学术

Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease

Published:2017-06-10 Issue:5 Volume:268 Page:519-524
ISSN:0940-1334
Container-title:European Archives of Psychiatry and Clinical Neuroscience
language:en
Short-container-title:Eur Arch Psychiatry Clin Neurosci

Author:

Alexopoulos Panagiotis,Gleixner Lena-Sophie,Werle Lukas,Buhl Felix,Thierjung Nathalie,Giourou Evangelia,Kagerbauer Simone M.,Gourzis Philippos,Kübler Hubert,Grimmer Timo,Yakushev Igor,Martin Jan,Kurz Alexander,Perneczky Robert

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine

Link

http://link.springer.com/article/10.1007/s00406-017-0815-9/fulltext.html

Reference37 articles.

1. Dubois B, Feldman HH, Jacova C et al (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13(6):614–629. doi: 10.1016/S1474-4422(14)70090-0

2. McKhann GM (2011) Changing concepts of Alzheimer disease. JAMA 305(23):2458–2459. doi: 10.1001/jama.2011.810

3. Alexopoulos P, Kurz A (2015) The new conceptualization of Alzheimer’s disease under the microscope of influential definitions of disease. Psychopathology 48(6):359–367. doi: 10.1159/000441327

4. Martins-de-Souza D (2010) Is the word ‘biomarker’ being properly used by proteomics research in neuroscience? Eur Arch Psychiatry Clin Neurosci 260(7):561–562. doi: 10.1007/s00406-010-0105-2

5. Herukka S-K, Simonsen AH, Andreasen N et al (2017) Recommendations for cerebrospinal fluid Alzheimer’s disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer’s Dement 13(3):285–295. doi: 10.1016/j.jalz.2016.09.009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regressive Autism Spectrum Disorder: High Levels of Total Secreted Amyloid Precursor Protein and Secreted Amyloid Precursor Protein-α in Plasma;Frontiers in Psychiatry;2022-03-08

2. Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study;Alzheimer's & Dementia;2022-02-20

3. Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future;Journal of Pharmaceutical and Biomedical Analysis;2022-02

4. Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases;Current Neuropharmacology;2021-08-11

5. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer’s disease;Archives of Gerontology and Geriatrics;2020-03